Showing results (61-70 of 183) with videos related to
Sort By:
Pageof 19
Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.Haematologica|September 24, 2013
Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donorsDavid I Marks, Kwang Ahn Woo, Xiaobo Zhong, et al.The New England Journal of Medicine|November 27, 2004
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemiaMary J Laughlin, Mary Eapen, Pablo Rubinstein, et al.Blood|November 27, 2013
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemiaAdele K Fielding, Jacob M Rowe, Georgina Buck, et al.Blood|October 13, 2006
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 studyAdele K Fielding, Susan M Richards, Rajesh Chopra, et al.Haematologica|August 4, 2009
Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remissionBella Patel, Keiren E Kirkland, Richard Szydlo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Allogeneic hematopoietic cell transplant for prolymphocytic leukemiaMatt E Kalaycio, Manisha Kukreja, Ann E Woolfrey, et al.Mycoses|August 27, 2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplantCarlos Solano, Monica Slavin, Alissa J Shaul, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 14, 2020
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular TherapyAbraham S Kanate, Navneet S Majhail, Bipin N Savani, et al.Pageof 19